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1. Introduction 
The inhibition of thrombin by the plasma protease 
inhibitor antithrombin has been extensively studied 
as a model for the action of antithrombin as an inhib- 
itor of all the serine proteases of the intrinsic coagu- 
lation system. The inactivation reaction, which is 
greatly accelerated by heparin, involves the formation 
of an inactive, stable, equimolar complex between 
enzyme and inhibitor [ 1,2]. This complex resists 
dissociation by protein-denaturing agents, such as 
sodium dodecylsulphate (SDS) or guanidine-HCl 
[2,3]. The integrity of the denatured complex may 
be due to a covalent bond [3], most likely an acyl 
bond between the active site serine of the enzyme 
and the arginine in the active site of the inhibitor 
(see below). However, the interactions stabilizing the 
native complex are essentially unknown. 
The antithrombin-thrombin complex can be dis- 
sociated by certain chemical agents, e.g., hydroxyl- 
amine, ammonia or high pH in the presence or 
absence of SDS [3-51. Dissociation by these agents 
does not release intact antithrombin from the com- 
plex, but a disulfide-linked, two-chain form of the 
inhibitor [4,.5]. This proteolytically modified aFti- 
thrombin, which is inactive, is also formed free in 
solution during the reaction between antithrombin 
and thrombin [6]. It is cleaved at a single site, an 
Arg-Ser bond near the C-terminal end of the chain 
[7]. The cleavage site has been suggested to constitute 
the active site of antithrombin [5,7,8]. 
This paper demonstrates that purified antithrom- 
bin-thrombin complex slowly dissociates also under 
physiological conditions, i.e., in the absence of any 
denaturing or dissociating agents. This spontaneous 
dissociation also produces only the modified form of 
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the inhibitor and no intact antithrombin. However, 
active thrombin is released concurrently from the 
complex. 
2. Materials and methods 
Bovine antithrombin was prepared as in [9]. Hepa- 
rin was purified and coupled to cyanogen bromide- 
activated agarose as detailed in [lo]. Bovine a-throm- 
bin was a generous gift from Dr Craig Jackson, 
Washington University, St Louis, MO. 
Bovine antithrombin-thrombin complex was pre- 
pared by a modification of the procedure in [S]. 
Bovine antithrombin (in 0.05 M Tris-HCl (pH 7.4) + 
0.1 M NaCl) was mixed with heparin in protein: 
polysaccharide, 10: 1 (w/w). Thrombin was then 
added to a final 4.fold molar ratio of inhibitor to 
enzyme. The mixture was kept at +4”C for 15 min 
then applied to a heparin-Sepharose column in 
0.05 M Tris-HCl (buffer (pH 7.4) + 0.1 M NaCl. 
A gradient to the same buffer containing 0.8 M NaCl 
was started, and the complex was eluted at an ionic 
strength of -0.5. Further purification was achieved 
by gel chromatography on Sephacryl S200 [ 51. The 
final product contained 25% of intact complex. 
Some proteolytically degraded complex [ 1 l] and 
minor amounts of intact and modified antithrombin 
were evident (see fig.1). 
A synthetic, reversible, thrombin inhibitor, 
4-(3.nitrophenoxymethyl) benzamidine-HCl (com- 
pound 10 of [ 12]), was a kind gift from Dr J. D. 
Geratz, Department of Pathology, University of 
North Carolina at Chapel Hill, NC. This inhibitor has 
a Ki value with bovine thrombin of 3.3 X 10” M 
at pH 8.1 and 37°C (J. D. Geratz, personal commu- 
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nication). Another synthetic, irreversible, thrombin 
inhibitor, D-Phe-Pro-ArgCH*Cl [ 131 was generously 
donated by Dr E. Shaw, Brookhaven National 
Laboratory, Upton, NY. 
SDS- polyacrylamide gel electrophoresis under 
reducing conditions essentially followed the method 
in [ 141. Samples were boiled for 60 s in 1% SDS and 
0.45 M fl-mercaptoethanol, and were rapidly chilled. 
Gels were stained with Coomassie brilliant blue R250 
and were scanned at a wavelength of 570 nm. 
Thrombin activity was assayed as in [5]. Protein 
concentrations were measured spectrophotometri- 
tally with the use of the specific absorption coeffi- 
cients in [5,6,15]. 
3. Results 
The spontaneous dissociation of the antithrom- 
bin-thrombin complex at 37°C was monitored by 
removing aliquots from a solution of the complex 
(in 0.02 M phosphate buffer (pH 7.4) t 0.18 M NaCl) 
at different times and analysing these samples by 
SDS-polyacrylamide gel electrophoresis under reduc- 
ing conditions. Initially, phosphate buffer was used, 
since Tris, being a weak nucleophile, may dissociate 
the antithrombin-thrombin complex [4]. However, 
later experiments showed that similar results were 
obtained in both buffer systems. Gels l-3 of fig.1 
show that the amount of intact antithrombin- throm- 
bin complex has decreased markedly after 66 h at 
37”C, concomitant with an increase in the amounts of 
the large chain of modified antithrombin and the 
B-chain of thrombin. The small chain of modified anti- 
thrombin and the A chain of thrombin, which have 
MI < 5000, are not easily visible on the gels. No 
increase of the small amounts of proteolytically 
degraded complex or intact antithrombin is evident 
from the gels. The large chain of modified anti- 
thrombin migrates ahead of the intact inhibitor under 
reducing conditions [6] and was identified by adding 
intact antithrombin or purified, modified antithrom- 
bin [6] to some gels. 
The time course of the dissociation is illustrated in 
fig.2. The proportions of the components were esti- 
mated by gel scanning and therefore are only approxi- 
mate. The disappearance of the antithrombin- 
thrombin complex is parallelled by a corresponding 
appearance of the large chain of modified antithrom- 
Fig.1. Dissociation of antithrombin-thrombin complex at 
37”C, monitored by SDS-polyacrylamide gel electrophoresis 
under reducing conditions. (1) Antithrombin-thrombin com- 
plex. (2) Complex kept at 37°C for 66 h. (3) As in (2) but 
with intact antithrombin added before electrophoresis. (4) 
Antithrombin-thrombin complex (this preparation con- 
tained more proteolytically degraded complex [ 111 than that 
of (1). (5) Complex kept at 37°C for 90 h in the presence of 
the irreversible inhibitor D-Phe-Pro-ArgCH,Cl. The inhibi- 
tor was added at the start of the experiment in a S-fold molar 
ratio to the complex, followed by equimolar amounts every 
12 h. (6) As in (5) but with intact antithrombin added before 
electrophoresis. (ATT) antithrombin-thrombin complex; 
(AT) intact antithrombin; (ATM) large chain of modified 
antithrombin; (T) thrombin B-chain. The complex was 
3 mg/ml, and the solvent was 0.02 M sodium phosphate 
buffer (pH 7.4) + 0.18 M NaCl. Amounts of 20 clg (gels l-3) 
or 30 pg (gels 4-6) protein were applied to each gel. 
bin and the thrombin B chain, while the small 
amount of intact antithrombin originally present in 
the complex preparation remains constant (not 
shown). Fig.2 also shows the release from the com- 
plex of thrombin activity, measured as amidolytic 
activity against a synthetic tripeptide substrate in a 
separate dissociation experiment. However, the 
apparent rate of this release was much lower than 
would be expected from the rate of appearance of 
the thrombin B chain in the electrophoretic experi- 
ments. A major part of the thrombin liberated from 
the complex thus most likely was inactivated during 
the prolonged incubation at 37’C. 
In some dissociation experiments the active 
thrombin released from the antithrombin-thrombin 
complex was inhibited by synthetic thrombin inhibi- 
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Fig.2. Rate of dissociation of antithrombin-thrombin com- 
plex and of appearance of the dissociation products at 37°C. 
The complex was dissociated as in fig.1 without any inhibitor 
present. Samples were removed at different times and ana- 
lysed by SDS-polyacrylamide gel electrophoresis under 
reducing conditions. The proportions of the components 
were estimated by gel scanning. Samples were also analysed 
for thrombin activity by a spectrophotometric assay, using a 
synthetic substrate, D-Phe-Pip-kg-pNA [S]. The results of 
this assay were expressed as % of the maximum potential 
thrombin activity; the latter was estimated from assays of 
pure thrombin and from the amount of thrombin calculated 
to be present in the complex. (o-o) Intact + proteolyti- 
tally degraded complex. The amount of degraded complex 
remained at <5% of the total absorbance throughout the 
experiment; (e-e) modified antithrombin; (b---o) 
thrombin B chain; (m---m) thrombin activity. 
tors. Gels 4-6 of fig.1 show that only modified anti- 
thrombin and no intact antithrombin was released 
from the complex also in the presence of the irrever- 
sible inhibitor D-Phe-Pro-ArgCHaCl. Another dis- 
sociation experiment in the presence of 5 mM revers- 
ible inhibitor 4.(3nitrophenoxymethyl) benzami- 
dine-HCl gave an identical result, which is not pre- 
sented. These observations verify the conclusion in 
[5] that modified antithrombin is released as such 
from the antithrombir-thrombin complex and not 
as intact antithrombin which is subsequently trans- 
formed by the active thrombin released concurrently. 
4. Discussion 
These experiments show that purified antithrom- 
bin-thrombin complex spontaneously, but slowly, 
dissociates to the modified, two-chain form of the 
inhibitor and to active thrombin. The liberation of 
modified antithrombin from the complex by dis- 
sociating agents in [ 51 thus is not an artifact pro- 
duced by these agents. The spontaneous release of 
modified antithrombin from the antithrombin- 
thrombin complex adds further support to the pro- 
posal that the cleavage site in modified antithrombin 
is in the active site of the intact inhibitor [5,7,8]. 
The results further show that after thrombin ini- 
tially has reacted with antithrombin to form an inac- 
tive complex, it is not permanently trapped in this 
complex. This has often been tacitly assumed because 
of the marked stability of the complex, notably its 
resistance to dissociation by protein-denaturing 
agents. Instead, the antithrombin-thrombin complex 
can be regarded as an enzyme-substrate complex, 
which is unusually stable, but nevertheless lowly 
decomposes to free enzyme and a product in which 
the active-site peptide bond of the inhibitor has been 
hydrolysed. The formation and decay of the complex 
most likely occurs via the same intermediates that are 
generally acknovvledged to occur in normal peptide 
bond hydrolysis catalysed by serine proteases [16]. 
The dominant state of the scissile peptide bond of 
the inhibitor in the complex, which defines the rate- 
limiting step of this slow enzymatic reaction, has not 
yet been characterized [S]. However, the slow 
hydrolysis of the inhibitor is reminiscent of, and may 
be analogous to, the slow deacylation step in the 
hydrolysis of those synthetic substrates for serine 
proteases which show initial-burst kinetics, e.g., 
p-nitrophenyl-p’guanidino benzoate [ 16,171. 
The slow dissociation of the antithrombin- 
thrombin complex to active enzyme and inactive 
inhibitor means that the inactivation of thrombin by 
antithrombin is a form of so called temporary inhibi- 
tion [ 181. This was, in fact, suggested some time ago 
[ 191 from experiments with impure reagents. They 
observed that thrombin activity regenerated from a 
mixture of thrombin and antithrombin, while anti- 
thrombin activity did not reappear. 
The rate of formation and dissociation of the 
antithrombin-thrombin complex was studied [20]. 
The kinetics observed could be described by a simple 
one-step reversible reaction between enzyme and 
inhibitor, leading to an equilibrium.with Kd -lo-” M. 
This mechanism implies that only very low concen- 
trations of the free proteins would be detected in a 
solution of purified antithrombin-thrombin com- 
plex, and also that only intact antithrombin would 
dissociate from the complex. Both these predictions 
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are contrary to these observations. However, only 
the dissociation of the nascent antithrombin-throm- 
bin complex was monitored and a slow conversion of 
this complex to a more stable form noted [20]. This 
may be the form of the complex that we have studied, 
since our purification procedure lasted 224 h. Our 
results thus show that the mechanism of inhibition is 
more complicated than proposed [20]. Further studies 
to elucidate this problem by characterizing the kinet- 
ics of dissociation of the nascent and mature forms of 
the antithrombin-thrombin complex are in progress. 
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